Himuka is a clinical-stage biotech company engaged in the research and development of novel therapies for unmet medical needs. Himuka is conducting a Phase 1 clinical trial of HM201, a novel adrenomedullin based peptide drug candidate developed for the treatment of Inflammatory bowel disease.
Social Link - Linkedin: http://www.linkedin.com/company/himuka-am
Employee Count: 1
Keywords: biotechnology research